Journal of Clinical Oncology

Reply to C. Fuchao et al

S Sabashini K. Ramchand (Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...) E Ego Seeman (Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...) R Rudolf Hoermann (Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...) A Ali Ghasem-Zadeh (Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...) M Mathis Grossmann (Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 2
Published January 10, 2025
Pages 237-238
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (5)

S

Sabashini K. Ramchand

Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...

E

Ego Seeman

Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...

R

Rudolf Hoermann

Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...

A

Ali Ghasem-Zadeh

Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...

M

Mathis Grossmann

Sabashini K. Ramchand, MBBS, BMedSci, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ego Seeman, MD, MBBS, AO, FRACP, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia, Department of Endocrinology, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Rudolf Hoermann, MD, PhD, Department of Medicine, Austin Health, University of Melbourne, Melbourne, VIC, Australia; Ali Ghasem-Zadeh, PhD, MSc,...

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001